Alcon买下LENSAR, 一家机器人白内障手术技术公司, 价格高达4.3亿美元。 Alcon buys LENSAR, a robotic cataract surgery tech firm, for up to $430 million.

一家主要的眼科护理公司Alcon同意以4.3亿美元的价格收购一家专门从事机器人白内障激光系统的医疗技术公司LENSAR。 Alcon, a leading eye care company, has agreed to acquire LENSAR, a medical technology firm specializing in robotic cataract laser systems, for up to $430 million. 这包括LENSAR的精简软件和机器人处理系统,目的是加强Alcon在Femto second激光辅助白内障手术方面的服务。 This includes LENSAR's Streamline software and robotic treatment system, aimed at enhancing Alcon's offerings in femtosecond laser-assisted cataract surgery. Alcon公司将支付每股14美元,根据未来业绩里程碑,可能额外支付最高为每股2.75美元。 Alcon will pay $14 per share, with potential additional payments up to $2.75 per share based on future performance milestones. 预计这项交易将在2025年中至晚期结束。 The deal is expected to close by mid-to-late 2025.